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Abstract
Purpose: Studies on drug use in transgender populations, particularly those in resource-limited settings, are
scarce. Considering that drug use can be a coping mechanism to deal with stigma and traumatic experiences,
we examined associations between stigma, trauma, and drug use in a national sample of transgender women
from the Dominican Republic.
Methods: Bivariate analyses examined differences between drug users and abstainers (n = 287). Multivariate an-
alyses reported odds ratios (OR) with general drug, marijuana, and cocaine use as outcomes (n = 243).
Results: A quarter of respondents (24.5%) experienced sexual abuse, 12.1% were tortured, and 20.1% experi-
enced a murder attempt. More than a quarter reported using illegal drugs (26.1%). Drug users had lower socio-
economic status; 30.0% of drug users had a primary level of education or less (18.2% of abstainers) and 17.6% of
drug users had higher income, defined as greater than 10,001 pesos (*$210 United States Dollars, USD) per
month (28.1% of abstainers). More than half of drug users experienced some form of trauma (51.4%) compared
to 43.5% of abstainers, and 28.4% of drug users, compared to 17.1% of abstainers, experienced a murder attempt
on her life. Independent sample t-tests found significant differences between drug users and abstainers. Trans-
gender women who experienced sexual abuse had three times high odds of using cocaine. Drug users were
more likely to have experienced sexual abuse and attempted suicide ( p < 0.05 for both). Respondents who
attempted suicide had higher odds of using drugs generally and using marijuana specifically, compared to re-
spondents who had not attempted suicide (OR = 2.665 and 3.168, respectively). Higher scores on the stigma scale
were associated with higher odds of any drug use and cocaine use (OR = 1.132 and 1.325, respectively).
Conclusions: Although some nations have implemented antidiscrimination policies protecting transgender cit-
izens, these policies are not consistently enforced. Eliminating stigma and stigmatizing policies may reduce rates
of drug use as a coping mechanism.
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Introduction
Globally, transgender women are economically mar-
ginalized, experience hostility in the communities in
which they reside, and are more likely to engage in
high-risk behaviors, particularly those associated with
HIV and sexually transmitted infections compared
to other women.1–7 These negative exposures and
experiences are exacerbated in resource-limited set-
tings where nontraditional gender identities are vehe-
mently rejected, resulting in transgender women
being overtly ostracized.8 Experiencing this kind of
stigma and discrimination is associated with coping
1University of Alabama at Birmingham, Birmingham, Alabama.
2Queen Mary University of London, London, United Kingdom.
3United Nations Family Planning Association (UNFPA), Tegucigalpa, Honduras.
4Institute for Tropical Medicine and Global Health, Universidad Iberoamericana, Santo Domingo, República Dominicana.
5Centro de Orientación e Investigación Integral (COIN), Santo Domingo, Dominican Republic.
*Address correspondence to: Henna Budhwani, PhD, MPH, Health Care Organization and Policy, University of Alabama at Birmingham, 310 Ryals Public Health Building,
1665 University Boulevard, Birmingham, AL 35294, E-mail: budhwani@uab.edu
ª Henna Budhwani et al. 2017; Published by Mary Ann Liebert, Inc. This is an Open Access article distributed under the terms of the Creative Commons







mechanisms such as drug use, alcohol consumption,
and engagement in high-risk sexual behaviors9,10;
these risk behaviors can be intensified in transgen-
der women, those with lower socioeconomic status,
and in those living in resource-poor settings.11 More-
over, in the Dominican Republic where one-third of
transgender women believe it is difficult to access
healthcare services due to stigma and shame, the likeli-
hood of engaging in mental healthcare for substance
use is severely reduced.5,9 Considering the socially pre-
carious environment affecting transgender women re-
siding in the Dominican Republic, we examined these
women’s drug use patterns to better understand these
behaviors and their associates in such a hard-to-reach
population.
Globally, 246 million people use illicit drugs, and 27
million have a drug use disorder or dependence.12,13 In
2013, there were 187,100 drug-related deaths reported
worldwide.12 In Latin America and the Caribbean, the
drug-related mortality rate is 18.4 per million,12 with co-
caine being the primary drug of concern in the Caribbe-
an.12 In the Dominican Republic, powder cocaine, crack
cocaine, heroin, and marijuana are used at particularly
high rates.14 In fact, after only 1 year and 3 months of
operation, the Joint Airport Interdiction Task Forces
in Santo Domingo and Punta Cana seized 227 kg of co-
caine, 11 kg of heroin, 1.1 kg of marijuana, and $763,000
USD in 2016.15 These high confiscation rates not only
indicate the amount of drugs available in the Dominican
Republic but also reflect that the Dominican Republic is
a transit country for trafficking drugs to other destina-
tions.15 Although, the Dominican Republic’s National
Statistical Office does not have a formal surveillance
and reporting system for drug use and drug-related
deaths,16 other sources estimated 2.3% of men and
0.6% of women in the Dominican Republic are drug
users.2 In addition, the Inter-American Drug Abuse
Control Commission estimated there to be *2000 her-
oin users in the Dominican Republic based on a study
published jointly by its Inter-American Observatory
on Drugs and the National Drug Council of the Domin-
ican Republic.17 Although this study did not focus
on injectable drugs, such as heroin, injectable drug use
patterns in the Dominican Republic are particularly rel-
evant to drug studies in the Caribbean, since injectable
drug use is on the rise in the Dominican Republic.18–20
Moreover, this alarming uptick has been attributed
to the social importation of injectable drug use behav-
ior from residents (e.g., deportees from the United
States) who lived outside of the country, but who
have returned or who maintain connections to indus-
trialized nations.18–20
In addition, according to the most recent report
by the Dominican Republic’s National Council for
HIV and AIDS (CONAVIHSIDA), those who identify
as men who has sex with men (MSM) or transgender
women reported significantly higher drug use than
the general population.2 Among Santo Domingo-
based MSM and transgender women, the most com-
monly used illegal drugs were marijuana (60.0%),
cocaine (24.9%), and crack cocaine (13.3%).2 In a small
mixed-methods study examining drug use patterns
among transgender female sex workers, 65% tested
positive for recent drug use and more than half of the
sample (52.8%) considered themselves to be at ‘‘high
risk’’ of becoming addicted to drugs,21 in part, due to
the deleterious social forces affecting transgender
women in high-stigma settings. Although research on
substance use rarely reports sexual orientation or gender
identity, and the majority of studies that do are focused
on HIV risk rather than drug use,22 some studies sug-
gest higher prevalence of alcohol and drug use in trans-
gender women compared with the general population
and a strong association between psychosocial risk fac-
tors and substance use.10,20 Again, primary reasons for
drug use in transgender populations are to cope with
transphobia, discrimination, violence, stressful life
events, and stigma.10,23–25
The injurious effects of stigma are well documented;
stigma is linked to risk behaviors and coping mecha-
nisms, such as drug use.26–28 Stigma is fundamentally
social in which one group of people (such as trans-
gender women) is labeled as deviant, and perpetu-
ally discredited because of their characteristics or
behaviors.26,29 Because stigma positions one group as in-
herently inferior or less valid according to the perspec-
tive of another, dominant group, stigma manifests and
is reproduced throughout social structures and during
interpersonal interactions.26,27 Theoretically speaking,
there are three realms of stigma—perceived stigma,
enacted stigma, and internalized stigma.28,30 Perceived
stigma refers to an individual’s subjective awareness of
discriminatory attitudes from other people or society at
large; enacted stigma is an individual’s lived experience
of negative treatment; and internalized stigma refers to
an individual developing negative beliefs about him or
herself as a result of accepting the repeated disparaging
views of others.28,30 It is precisely this type of social rejec-
tion that encourages transgender women to engage in
coping behaviors such as drug use and avoid seeking
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mental health and drug use treatment services, among
others.9,27
Considering the dearth of research on the drug use
patterns of transgender women who reside in resource-
limited settings, our study is particularly novel. Find-
ings from this work have the potential to inform public
health programs and policy designed to reduce drug
use in transgender women not only in the Dominican
Republic but also in similar settings across the Carib-
bean and Latin America. In view of prior research on
stigma, drug use, and coping behaviors in transgender
women, we hypothesized that stigma and trauma
would be associated with drug use in transgender
women residing in the Dominican Republic.
Methods
Data for this study are from the 2015 Dominican
Republic Transgender Health Needs Study (THNS),
collected by Centro de Orientación e Investigación
Integral (COIN) and funded by the National Council
for HIV and AIDS (CONAVIHSIDA) representing
the Dominican Republic Ministry of Health. Facilitated
interviews with transgender women were employed to
collect quantitative survey data. Transgender women
who self-identified with a biological sex as male and
presented and identified with a gender of woman,
met the inclusion criteria. Transgender community-
based organization leaders from Trans Amigas Siempre
Amigas, Coalicion de Mujeres Trans, Trasvesti y Tran-
sexuales Trabajadores Sexuales, and Trans Este Pode-
mos Avanzar were engaged in design, validation, and
implementation of this questionnaire. The question-
naire was previously implemented in Central American
countries to measure the health needs of their trans-
gender populations, and was adapted to the linguistic
Spanish dialect of the Dominican Republic. Data
were collected on the following: demographics, sex
partners, sexual history, use of condoms and lubricants,
sexually transmitted Infections, healthcare utilization,
gender-based violence, stigma and discrimination, use
of hormones and other feminization processes, social
inclusion/isolation, and stress.
As recommended by the Joint United Nations Pro-
gramme on HIV/AIDS (UNAIDS), this study leveraged
the PLACE method of data collection. Specifically,
snowball sampling using peers from the different com-
munities was employed. Data were collected from
transgender women in Santo Domingo, La Altagracia,
Puerto Plata, Santiago, Dajabón, Independencia, and
Barahona. Site selection was informed by the Ministry
of Health’s internal surveillance data on locations
where the most-at-risk for HIV infection are located
and included the United States President’s Emergency
Plan for AIDS Relief’s (PEPFAR) priority provinces.
Interviews were conducted in neutral spaces, such as
restaurants and parks, recommended by the local
transgender community and community-based organi-
zations working in study communities.
Ethical approval for the study was provided by El
Consejo Nacional de Bioética en Salud (CONABIOS)
in the Dominican Republic, and informed consent
was collected verbally as verbal consent is a modality
often used in participatory action research when work-
ing with reported low-literacy populations.31,32 It has
been found that when verbal consent is designed and
implemented thoughtfully, it leads to voluntary partic-
ipation and thorough comprehension of the study.
Written consent, on the other hand, may cause psycho-
social discomfort when the respondent cannot read or
write.33,34 The verbal consent process we employed in-
volved three steps: (1) provision of a thorough verbal
description about the participant’s rights and the
study purpose in simple language, (2) an explanation
of topic covered, and (3) request of verbal consent
that she is participating freely, without coercion. The
verbal consent was witnessed by a senior investigator.
The University of Alabama at Birmingham’s Institu-
tional Review Board provided ethical approval for sec-
ondary data analysis (No. N150803004).
Dependent variable
Drug use was measured through the prompt and ques-
tion, ‘‘Now we are going to talk about the use of drugs
and alcohol. I am going to read a list, please, indicate in
what frequency you used each drug in the past 6
months.’’ The list included marijuana, cocaine, crack,
heroin, injectable drugs, inhalant drugs (glue and thin-
ner), amphetamines (pills), and ecstasy. Responses in-
cluded the following: ‘‘daily,’’ ‘‘one time a week,’’
‘‘multiple times a month,’’ ‘‘multiple times during the
past 6 months,’’ and ‘‘I don’t use this.’’ Because of low
affirmative response rates on the majority of drugs
listed, three dummy dependent variables are utilized
in the study: whether the respondent has used (1)
any drugs, (2) marijuana, or (3) cocaine, in the past 6
months (1 = yes; 0 = no).
Independent variables
Three demographic variables were included in the anal-
ysis: age, income, and educational attainment were
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included as controls. Age was measured as a continuous
variable in years. Monthly income in pesos was mea-
sured as a categorical variable (1 = 0–1000 (*$0–$21
USD); 2 = 1001–5000 (*$21–$105 USD); 3 = 5001–
10000 (*$105–$210 USD); and 4 = more than 10,001
(more than $210 USD per month) pesos). As a point
of reference, minimum wage in the Dominican Republic
is about 11,400 pesos per month, or about $241 USD.
Educational attainment was measured using three di-
chotomous variables: primary school or less [referent],
secondary school, or postsecondary school (technical
school or university).
Trauma was measured with four dichotomous vari-
ables of whether the respondent since the age of 14 had
experienced (1) sexual abuse, (2) psychological abuse,
(3) torture, and (4) if someone had attempted to kill
the respondent (yes = 1; 0 = no). Attempted suicide
was a dichotomous variable representing whether or
not respondents answered affirmatively to the ques-
tion, ‘‘Have you attempted suicide?’’ (1 = yes; 0 = no).
Stigma was measured on a 0–9 scale (Cronbach’s
a = 0.827) and measured how many times in the past
3 months the respondent had experienced the follow-
ing events, specifically due to the fact that [she] is a
trans person: (1) arguments between her parents, (2)
problems with her brothers or sisters, (3) arguments
between her and her parents, (4) arguments with
other family members, (5) problems with her profes-
sors or bosses, (6) problems with classmates or cowork-
ers, (7) arguments or disagreements with close friends,
(8) lost close friendships, and (9) problems with the po-
lice or other authorities. Family Health International
(FHI) originally employed this stigma scale during
their 2012 National Surveillance Study conducted in
the Dominican Republic. These measures were origi-
nally developed for use with men who have sex with
men (MSM, which was the broad category within
which transgender women were classified previously),
and were therefore adjusted during the pilot testing
phase of this study for acceptability among transgender
populations.
Statistical analyses
In addition to completing univariate and bivariate an-
alyses (n = 287), we employed multivariate analysis
using logistic regression. Listwise deletion was uti-
lized, and outcomes were (1) any drug use (n = 240),
(2) marijuana use (n = 243), and (3) cocaine use




Univariate and bivariate statistics are reported in
Table 1. The average age of our sample was 26.1
years with those who used drugs in the past 6 months
being slightly older (26.6) than those who had not
(25.9). Approximately a quarter of respondents had a
monthly income of over 10,000 pesos ($210 USD)
per month, meaning three-quarters of respondents
had an income under the Dominican Republic’s mini-
mum wage level. Roughly 21% of the sample had a pri-
mary school education or less. More than a quarter of
the sample had used drugs in the past 6 months
(26.1%). 21.5% of the sample had used marijuana and
10.5% had used cocaine.




% of drug users
(n = 75)
% of nondrug users
(n = 212)
t(df)
Used drugs 26.1 100.0 00.0 —
Cocaine 10.5 38.7 — —
Marijuana 21.5 78.7 — —
Inhaled drugs 2.0 6.7 — —
Crack 1.4 5.3 — —
Other (e.g., heroin and ecstasy) 4.4 5.6 — —
Experienced trauma 45.6 51.4 43.5 1.157(272.000)
Sexual abuse 24.5 36.0 20.3 2.516(113.434)*
Psychological abuse 32.2 32.0 32.2 0.034(281.000)
Torture 12.1 16.0 10.7 1.114(114.073)
Attempted murder 20.1 28.4 17.1 1.917(111.451)
Attempted suicide 21.3 32.0 17.5 2.417(110.270)*
Five or greater on stigma scale 34.1 42.9 30.9 1.751(115.402)
Income ( > 10,001 pesos/month) 25.3 17.6 28.1 1.924(151.238)
Education (primary or less) 21.2 30.0 18.2 1.931(111.600)
Mean age 26.1 26.6 25.9 0.694(285.000)
*p < 0.05.
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We found a high level of trauma present in our sam-
ple. Almost half (45.6%) of respondents experienced
some form of trauma; 24.5% experienced sexual
abuse, 32.2% experienced psychological abuse, 12.1%
were tortured, and 20.1% experienced a murder at-
tempt on her life. The rate of trauma (any of the four
types) was higher (51.4%) in those who had used
drugs compared to those who had not (43.5%). How-
ever, when examining the statistical effects of each
trauma indicator individually, independent sample t-
tests showed only significant differences between
drug users and abstainers in terms of experiencing sex-
ual abuse ( p < 0.05).
Almost a quarter of the sample (21.3%) reported
attempting suicide and more than a third of the sample
scored a five or greater on the stigma scale (34.1%).
Drug users were also more likely to have attempted sui-
cide than abstainers ( p < 0.05).
Multivariate analyses
In terms of the trauma measures, experiencing psycho-
logical abuse was associated with lower odds of any
drug use (odds ratio [OR] = 0.423, p < 0.05, confidence
interval [95% CI] = 0.187–0.955). However, experienc-
ing sexual abuse was associated with over three times
greater odds of cocaine use (OR = 3.381, p < 0.05, 95%
CI = 1.069–10.688). Transgender women who had
attempted suicide had over two and a half times greater
odds of any drug use (OR = 2.665, p < 0.05, 95%
CI = 1.165–6.096) and over three times greater odds of
using marijuana (OR = 3.168, p < 0.01, 95% CI = 1.361–
7.370), but not cocaine use. In contrast, experiencing
stigma was associated with higher odds of cocaine use
(OR = 1.270, p < 0.01, 95% CI = 1.068–1.510), but not
any drug use or marijuana use.
The only demographic variable significantly related
to drug use was having a postsecondary education. Hav-
ing a postsecondary education was associated with
lower odds of using any drugs (OR = 0.268, p < 0.05,
95% CI = 0.085–0.846) and marijuana (OR = 0.235,
p < 0.05, 95% CI = 0.069–0.798) compared to women
with a primary school education or less (Table 2).
Discussion
Our findings highlight basic drug trends in transgender
women residing in the Dominican Republic. First, rates
of trauma and negative exposures were high in our
sample. For example, more than a quarter of respon-
dents (26.1%) were illicit drug users. Although this
seems alarming compared to the 9.4% of the adult
American population that admits to using illegal
drugs, over 30% of American gender and sexual minor-
ities use drugs such as marijuana or cocaine, which is
close to the rate we found in our sample from the Do-
minican Republic.35,36 We hypothesized that stigma
and trauma would be associated with drug use in our
sample and found some support. Drug users had higher
rates of trauma than abstainers. Specifically, drug users
had higher rates of experienced sexual abuse, torture,
and having experienced a murder attempt. This held
true in the multivariate analyses with sexually abused re-
spondents having higher odds of drug use. The rates of
attempted suicide and stigma were higher for drug
users compared to abstainers, and significant associations
Table 2. Odds Ratios for Logistic Regression of Drug Use
Variables
Any drug usage Marijuana Cocaine
OR 95% CI OR 95% CI OR 95% CI
Experienced trauma
Sexual abuse 1.948 0.847–4.478 1.326 0.541–3.250 3.381* 1.069–10.688
Psychological abuse 0.423* 0.187–0.955 0.576 0.249–1.332 0.484 0.155–1.512
Torture 0.754 0.261–2.176 0.529 0.169–1.652 1.666 0.450–6.169
Attempted murder 1.126 0.452–2.802 1.211 0.472–3.108 0.899 0.232–3.474
Attempted suicide 2.665* 1.165–6.096 3.168** 1.361–7.370 0.899 0.263–3.079
Stigma scale 1.112 0.989–1.249 1.051 0.930–1.188 1.270** 1.068–1.510
Monthly income 0.921 0.662–1.279 0.864 0.609–1.226 1.125 0.692–1.829
Education
Secondary school 1.210 0.582–2.516 0.877 0.417–1.847 1.779 0.590–5.363
Postsecondary 0.268* 0.085–0.846 0.235* 0.069–0.798 0.179 0.018–1.765
Age 1.011 0.977–1.047 0.987 0.948–1.027 1.046* 1.001–1.092
Pseudo R2 0.131 0.102 0.124
n 240 243 242
**p < 0.01, *p < 0.05.
CI, confidence interval; OR, odds ratio.
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between these variables and drug use were evident in the
multivariate analysis with suicide attempters having
higher odds of using drugs in general and specifically
marijuana, and respondents who scored higher on the
stigma scale had higher odds of using cocaine.
Extending our findings to inform policy, we noted
that the current regulatory framework in the Domini-
can Republic does not consider drug use to be a public
health issue and has two important implications. First,
Article 7 of Law 50–88 on drugs and controlled sub-
stances severely penalizes both users and dealers/traf-
fickers; it does not distinguish between users and
dealers/traffickers for nonhallucinogenic substances
and opium and its derivatives, meaning that those
who use drugs are prosecuted in the same way and pos-
sibly receive the same extent of punishment as those
who supply and transport illicit drugs. In a country
that holds such deep stigma toward transgender pop-
ulations, this law could severely disadvantage transgen-
der women charged with drug use and tried in a court
of law, or could also encourage those who are recrea-
tional users to ‘‘deal’’ drugs, since there is no additional
penalty for doing so. Second, by criminalizing drug use
with the same severity as drug dealing—emphasizing
the criminal nature of the offense—rather than framing
it as a public health challenge, those who are charged
with drug-related offenses are not viewed as ill or in
need to treatment, but rather as a threat to civil society,
which could exacerbate the stigma transgender women
face in the Dominican Republic.
Furthermore, a legal barrier exists for accessing
treatment services, as well as limits treatment center re-
sources since they are unable to use low-dose opium-
based substances to wean patients off their use.17,37
While a dialogue on harm and risk reduction practices
is gaining ground in the Dominican Republic as evi-
denced by the sixth Latin American and first Caribbean
Conference on Drug Policy in Santo Domingo in Octo-
ber, 2016, and by the negotiation of a pilot study with
the University of Puerto Rico on medically assisted treat-
ment programs for intravenous drug users, the current
official orientation toward drug use is prohibitionist
and punitive. Culturally, drug use is more commonly
viewed as a moral shortcoming than a medical issue.38
Limitations should be carefully considered when ap-
plying findings. First, bias is expected in self-reported,
survey data, especially when the population is stigma-
tized with lower levels of socioeconomic status, such
as transgender women in the Dominican Republic. In
addition, some of our measures lacked specificity, re-
ducing extensibility of our findings. Certain terms,
such as torture, were not defined; thus, respondents
were left to interpret the meaning of these words.
Also, although our sample was collected nationwide,
the final sample size was small; more comprehensive
data collection could provide deeper insight. Finally,
causality cannot be inferred from cross-sectional data.
Future studies should consider our limitations when
designing and implementing subsequent studies with
this same population.
Conclusion
Globally, transgender women are traumatized, stigma-
tized, and stripped of their human rights. Although
progress has been made to support transgender rights
in some high-income nations, this advancement has
not occurred universally in resource-poor settings.38
The transgender community continues to be trauma-
tized at high rates, which robs transgender persons of re-
spect and dignity and has detrimental effects on physical
health, mental health, and social well-being.8,39–42
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